Literature DB >> 18095117

Comparison of 1H-MRS-detected metabolic characteristics in single metastatic brain tumors of different origin.

Mikhail F Chernov1, Yuko Ono, Osami Kubo, Tomokatsu Hori.   

Abstract

Various types of intracranial metastases exhibit different growth patterns, which can be reflected in their metabolic characteristics and investigated noninvasively by proton magnetic resonance spectroscopy (1H-MRS). The objective of the present study was comparison of the 1H-MRS-detected metabolic parameters in brain metastases of different origin. Twenty-five patients (15 men and 10 women; mean age, 62.0 years) with single, previously nontreated metastatic brain tumors were investigated by long-echo single-voxel volume-selected 1H-MRS. The primary cancer was located in the lungs (10 cases), colon and rectum (8 cases), breast (3 cases), kidney (2 cases), prostate (1 case), and cardiac muscle (1 case). Comparison of clinical and radiological variables, including type of tumor contrast enhancement and extension of peritumoral edema, did not disclose statistically significant differences in metastatic brain tumors of different origin. At the same time, comparison of 1H-MRS-detected metabolic characteristics revealed that metastases of colorectal carcinoma have greater content of mobile lipids (Lip) compared to other neoplasms. In conclusion, high Lip content in the viable brain metastases of colorectal carcinoma can be used as an additional diagnostic clue for noninvasive identification of these tumors and should be taken into consideration in cases of 1H-MRS-based differentiation of their recurrence and radiation-induced necrosis after radiosurgical or radiotherapeutic treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18095117     DOI: 10.1007/s10014-006-0198-5

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  6 in total

Review 1.  Brain metastases: neuroimaging.

Authors:  Whitney B Pope
Journal:  Handb Clin Neurol       Date:  2018

2.  Clinical Relevance of Single-Voxel (1)H MRS Metabolites in Discriminating Suprasellar Tumors.

Authors:  A Einstien; Rahul A Virani
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 3.  Advanced magnetic resonance imaging biomarkers of cerebral metastases.

Authors:  S J Mills; G Thompson; A Jackson
Journal:  Cancer Imaging       Date:  2012-08-10       Impact factor: 3.909

Review 4.  The role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosis.

Authors:  Rasheed Zakaria; Kumar Das; Maneesh Bhojak; Mark Radon; Carol Walker; Michael D Jenkinson
Journal:  Cancer Imaging       Date:  2014-04-22       Impact factor: 3.909

Review 5.  Magnetic resonance spectroscopy - Revisiting the biochemical and molecular milieu of brain tumors.

Authors:  Ashish Verma; Ishan Kumar; Nimisha Verma; Priyanka Aggarwal; Ritu Ojha
Journal:  BBA Clin       Date:  2016-04-12

6.  Brain Metastases of Non-Small Cell Lung Cancer: Magnetic Resonance Spectroscopy for Clinical Outcome Assessment in Patients with Stereotactic Radiotherapy.

Authors:  Congli Jia; Zhengquan Li; Dong Guo; Zhen Zhang; Jingming Yu; Guangdong Jiang; Xiaobo Xing; Shengjun Ji; Feng Jin
Journal:  Onco Targets Ther       Date:  2020-12-22       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.